Columbia Asset Management Biogen Inc. Transaction History

Columbia Asset Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $198,169 - $254,676	-885 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $224,977 - $293,394	-795 Reduced 47.32%	885 $250,000
Q2 2021 Aug 02, 2021	BUY	$259.0 - $414.71 $435,120 - $696,712	1,680 New	1,680 $582,000
Q1 2019 May 20, 2019	SELL	$216.71 - $338.96 $72,597 - $113,551	-335 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $34,812 - $44,093	-125 Reduced 27.17%	335 $101,000
Q3 2018 Nov 06, 2018	BUY	$293.51 - $383.83 $135,014 - $176,561	460 New	460 $163,000

999

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

Stay updated on Columbia Asset Management with notifications on news.